Clinical Trials Sponsored by Fudan University

Total 219724 results

Fudan University

Recruiting

Research on Risk Factors and Interventions of Polycystic Ovary Syndrome Complicated With Depression and Anxiety (PCOS)

Depression, Anxiety | PCOS (Polycystic Ovary Syndrome) of Bilateral Ovaries

China
Fudan University

Recruiting

GEMOX Combined With Donafenib and Tislelizumab in Biliary Tract Cancer

Biliary Tract Carcinoma

China
Fudan University

Recruiting

Fluzoparib and Camrelizumab in Treating Patients With R/M NPC That Progressed After First-line Chemotherapy

Nasopharyngeal Carcinoma | Nasopharyngeal Cancer

China
Fudan University

Recruiting

TACE Combined With Tislelizumab in Patients With Advanced Intrahepatic Cholangiocarcinoma

Intrahepatic Cholangiocarcinoma

China
Fudan University

Not yet recruiting

Stage I HER2 Positive Invasive Breast Cancer De-escalation Study(IRIS-C/D)

Breast Cancer
Fudan University

Not yet recruiting

CTC vs Radiography as the Evidence of Recurrence in Colorectal Cancer Patients

Colorectal Cancer | Circulating Tumor Cell
Fudan University

Not yet recruiting

Tislelizumab in Combination With Eribulin for Patients With Metastatic Previously heaviLy-treAted TriplE-negative Breast Cancer：A Prospective Multiple-center Phase II Study (TEMPLATE)

Triple Negative Breast Cancer

China
Fudan University

Recruiting

Toripalimab Based Induction Chemotherapy Followed by De-escalation Protocols in HPV-related OPSCC

Oropharyngeal Carcinoma | Immune Checkpoint Inhibitor | De-escalation

China
Fudan University

Recruiting

A Study of Capecitabine Versus S-1 as Adjuvant Therapy in Patients With Biliary Tract Carcinoma After Surgical Resection

Recurrence | Cholangiocarcinoma | Biliary Tract Neoplasms | Gall Bladder Cancer

China
Fudan University

Recruiting

PD-1 Inhibitor and Nab-paclitaxel and Bevacizumab in CUP

Cancer of Unknown Primary

China
Fudan University

Not yet recruiting

Sintilimab Combined With Bevacizumab Biosimilar for Potentially Resectable Intermediate HCC

Hepatocellular Carcinoma
Fudan University

Not yet recruiting

Pancreatic Cancer With Elevated Serum CA125 Were Compared With Those Who Did Not Receive Neoadjuvant Chemotherapy.

Pancreatic Adenocarcinoma
Fudan University

Recruiting

mFOLFOXIRI+Bev vs. mFOLFOX6+Bev for RAS Mutant Unresectable Colorectal Liver-limited Metastases

Liver Metastases | Colorectal Carcinoma

China
Fudan University

Recruiting

SBRT for Oligo-residual and Oligoprogressive NSCLC After Treatment With PD-1 Immune Checkpoint Inhibitors

NSCLC Stage IV

China
Fudan University

Recruiting

Guided Treatment Based on Mini-PDX in Metastatic Triple Negative Breast Cancer

Triple Negative Breast Cancer

China
Fudan University

Recruiting

Clinical Efficacy and sAfety of Intravenous Infusion of Nicorandil During Primary Percutaneous Coronary Intervention (CLEAN)

ST Elevation Myocardial Infarction | Percutaneous Coronary Intervention

China
Fudan University

Not yet recruiting

Camrelizumab and Apatinib for Neoadjuvant Therapy in Thyroid Cancer

Thyroid Cancer

China
Fudan University

Recruiting

The Safety and Efficacy of the Combination of Raltitrexed for Injection and Nab-Paclitaxel in Advanced Pancreatic Cancer

Pancreatic Cancer | Chemotherapy Effect

China
Fudan University

Recruiting

Sintilimab Combined With Chidamide in Treating Peripheral T Cell Lymphoma (Sincerely20)

Peripheral T-cell Lymphoma

China
Fudan University

Not yet recruiting

Cetuximab Re-challenge for Colorectal Cancer Liver Metastasis

Colorectal Cancer | Liver Metastases | Cetuximab
Fudan University

Recruiting

Anti-EGFR Therapy With IMRT Concurrent Chemoradiotherapy in Locally Advanced OPC Resistant to Induction Chemotherapy

Oropharyngeal Carcinoma

China
Fudan University

Recruiting

The Value of Palliative Primary Tumor Resection in Metastatic Colon Cancer

Surgery | Metastatic Colon Cancer

China
Fudan University

Not yet recruiting

SBRT for Oligo-metastatic Lesions After Systemic Treatment of Primary Metastatic Nasopharyngeal Carcinoma

Nasopharyngeal Carcinoma | Metastasis | Stereotactic Body Radiation Therapy

China
Fudan University

Recruiting

Carboplatin Intensified Chemotherapy for TRIple NEgative Breast Cancer(CITRINE) (CITRINE)

Triple-negative Breast Cancer

China
Fudan University

Recruiting

ScreenIng of Genetic Susceptibility Genes for Breast Cancer Patients in CHinese communiTies (SIGHT)

Breast Cancer | Genetic Susceptibility

China
Fudan University

Not yet recruiting

Efficacy and Safety of Paclitaxel Liposome and S-1 as First-line Therapy in \ Advanced Pancreatic Cancer Patients

Advanced Pancreatic Cancer

China
Fudan University

Recruiting

A Clinical Trial of Breast Cancer Neo-adjuvant Therapy Based on Molecular Pathway in FUSCC

Breast Cancer

China
Fudan University

Recruiting

Study Comparing EC-T Verses PCb in the Adjuvant Chemotherapy of Non-triple Negative Breast Cancer (PANSY)

Breast Cancer

China
Fudan University

Recruiting

SBRT in Combination With Sintilimab and GM-CSF for the Treatment of Advanced NSCLC

NSCLC Stage IV

China
Fudan University

Recruiting

Sentinel Node Biopsy Vs Observation After Axillary PET (SOAPET)

Breast Cancer

China
Fudan University

Recruiting

Hypofractionated Vs Conventional Fractionated Postmastectomy Radiotherapy for High Risk Breast Cancer

Breast Cancer

China
Fudan University

Recruiting

Laparoscopic vs Open Pancreatectomy for Body and Tail Pancreatic Cancer

Pancreatic Cancer | Surgery | Laparoscopy

China
Fudan University

Recruiting

Comparing 61.2 Gy Radiotherapy Dose Versus 50.4 Gy Radiotherapy Dose for Locally Advanced Esophageal Carcinoma

Esophageal Squamous Cell Carcinoma

China
Fudan University

Recruiting

ELobectomy for NSCLC by VATS Versus Thoracotomy (ECTOP-1007)

Carcinoma, Non-Small-Cell Lung

China
Fudan University

Recruiting

CRT Versus Surgery for Retroperitoneal or Paraaortic Lymph Node Recurrence of CRC

Colorectal Cancer | Retroperitoneal Lymph Node Metastasis | Para-aortic Lymph Node Metastasis

China
Fudan University

Recruiting

Adjuvant Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Versus no HIPEC in Locally Advanced Colorectal Cancer (APEC Study)

Locally Advanced Colorectal Cancer

China
Fudan University

Recruiting

Gemcitabine Plus Cisplatin Versus Gemcitabine Plus Carboplatin in Triple Negative Breast Cancer (TNBC) (TNBC)

Breast Cancer

China
Fudan University

Recruiting

Clinical Study of Antiviral and Aspirin Treatment in Liver Cancer After Radical Surgery

Recurrence | Hepatocellular Carcinoma

China
Fudan University

Active, not recruiting

XELOX for 4 Months Versus 6 Months in Gastric Cancer (LOMAC)

Gastric Cancer

China
Fudan University

Completed

SRT for Residual Oligometastases of NSCLC After 3rd Generation EGFR-TKIs

NSCLC Stage IV | EGFR Activating Mutation

China
Fudan University

Completed

Negative ER Expression Assessed by 18F-FES PET/CT in the MBC With ER-positive Primary Tumor

Breast Cancer

China
Fudan University

Completed

Fruquintinib in Refractory Metastatic Colorectal Cancer: A Real-world Study

Metastatic Colorectal Cancer | Colorectal Cancer | Refractory Colorectal Cancer

China
Fudan University

Active, not recruiting

Neoadjuvant Dose-dense EC Followed by ABX With PD-1 for Triple Negative Breast Cancer Patients (NeoTENNIS)

Triple Negative Breast Cancer

China
Fudan University

Active, not recruiting

An Umbrella Trial Based on Molecular Pathway for Patients With Metastatic TNBC. (FUTURE-SUPER)

TNBC - Triple-Negative Breast Cancer

China
Fudan University

Completed

IASLC Grading System as a Predictor for EGFR-TKI Therapy

Lung Cancer

China
Fudan University

Active, not recruiting

Fluzoparib and Abiraterone in the preSurgery Treatment of Prostate Cancer: FAST Trial

Neoadjuvant Therapy | High-risk Prostate Cancer

China
Fudan University

Active, not recruiting

A Phase II Study to Explore the Safety, Tolerability, and Preliminary Antitumor Activity of Sitravatinib Plus Tislelizumab or Combination With Nab-paclitaxel in Patients With Locally Recurrent or Metastatic Triple Negative Breast Cancer (TNBC) (SPARK)

Metastatic Breast Cancer

China
Fudan University

Completed

Deep Radiomics-based Fusion Model Predicting Bevacizumab Treatment Response and Outcome in Patients With Colorectal Liver Metastases

The Patients With CRLM Who Benefit More From Bevacizumab

China
Fudan University

Enrolling by invitation

Study of The Second-line Treatment of Advanced Gastric / Gastroesophageal Junction Adenocarcinoma With Envafolimab and Lenvatinib Combined With Paclitaxel-albumin

Gastric / Gastroesophageal Junction Adenocarcinoma

China
Fudan University

Active, not recruiting

A Longitudinal Study of the Trajectory of Financial Toxicity and Its Relationship With Symptom Burden in Breast Cancer Patients

Financial Toxicity

China

3

Subscribe